SCHEMBL21291168

SCHEMBL21291168

CC(C)c1cc(Cc2c(Br)cc(OCP(=O)(O)O)cc2Br)ccc1O

nearest known ligand 0.78

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
THRA P10827 19/20 0.78
THRB P10828 19/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL328469 0.87 THRA (1.00) THRATHRB
Mb07344 SCHEMBL29378732 0.87 THRB (1.00) THRATHRB
Mb07344 SCHEMBL282003 0.87 THRB (1.00) THRATHRB
SCHEMBL328320 0.86 THRA (0.77) THRATHRB
SCHEMBL21286574 0.85 THRB (0.76) THRATHRB
SCHEMBL4980997 0.83 THRA (0.72) THRATHRB
SCHEMBL21286583 0.83 THRB (0.79) THRATHRB
SCHEMBL19634301 0.83 THRB (0.79) THRATHRB
SCHEMBL19617453 0.82 THRB (1.00) THRATHRB
SCHEMBL13946957 0.82 THRB (0.85) THRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190255080-A1 METHOD OF REDUCING THYROID-ASSOCIATED SIDE EFFECTS CITIBANK, N.A., AS ADMINISTRATIVE AGENT 2019-08-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190255080-A1 METHOD OF REDUCING THYROID-ASSOCIATED SIDE EFFECTS TSHR, TPO, THRA THRA 3/4885THRB 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.